These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36407024)
1. Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty "Second Chance" Methadone Program. Moses TE; Rhodes GL; Tavakoli E; Christensen CW; Amirsadri A; Greenwald MK Subst Abuse; 2022; 16():11782218221138335. PubMed ID: 36407024 [TBL] [Abstract][Full Text] [Related]
2. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment. Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601 [TBL] [Abstract][Full Text] [Related]
3. Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville). Carrieri PM; Michel L; Lions C; Cohen J; Vray M; Mora M; Marcellin F; Spire B; Morel A; Roux P; PLoS One; 2014; 9(11):e112328. PubMed ID: 25393311 [TBL] [Abstract][Full Text] [Related]
4. Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic. Lister JJ; Brown S; Greenwald MK; Ledgerwood DM Subst Abus; 2019; 40(2):185-193. PubMed ID: 30888262 [No Abstract] [Full Text] [Related]
5. Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone? Srivastava A; Kahan M; Nader M Can Fam Physician; 2017 Mar; 63(3):200-205. PubMed ID: 28292795 [TBL] [Abstract][Full Text] [Related]
6. The impact of benzodiazepine use on methadone maintenance treatment outcomes. Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528 [TBL] [Abstract][Full Text] [Related]
7. Bridge clinic implementation of "72-hour rule" methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in care. Taylor JL; Laks J; Christine PJ; Kehoe J; Evans J; Kim TW; Farrell NM; White CS; Weinstein ZM; Walley AY Drug Alcohol Depend; 2022 Jul; 236():109497. PubMed ID: 35607834 [TBL] [Abstract][Full Text] [Related]
8. Characteristics and Outcome of Male and Female Methadone Maintenance Patients: MMT in Tel Aviv and Las Vegas. Adelson M; Linzy S; Peles E Subst Use Misuse; 2018 Jan; 53(2):230-238. PubMed ID: 28574738 [TBL] [Abstract][Full Text] [Related]
9. Baseline risk factors for drug use among African-American patients during first-month induction/stabilization on methadone. Lister JJ; Greenwald MK; Ledgerwood DM J Subst Abuse Treat; 2017 Jul; 78():15-21. PubMed ID: 28554598 [TBL] [Abstract][Full Text] [Related]
10. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397 [TBL] [Abstract][Full Text] [Related]
11. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Peles E; Schreiber S; Adelson M Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783 [TBL] [Abstract][Full Text] [Related]
12. Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial. Wu LT; John WS; Morse ED; Adkins S; Pippin J; Brooner RK; Schwartz RP Addiction; 2022 Feb; 117(2):444-456. PubMed ID: 34286886 [TBL] [Abstract][Full Text] [Related]
13. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864 [TBL] [Abstract][Full Text] [Related]
14. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117 [TBL] [Abstract][Full Text] [Related]
15. Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies. Gauthier G; Eibl JK; Marsh DC Drug Alcohol Depend; 2018 Oct; 191():1-5. PubMed ID: 30064001 [TBL] [Abstract][Full Text] [Related]
16. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Saxon AJ; Wells EA; Fleming C; Jackson TR; Calsyn DA Addiction; 1996 Aug; 91(8):1197-209. PubMed ID: 8828247 [TBL] [Abstract][Full Text] [Related]
17. A Web-Based Behavior Therapy Program Influences the Association Between Cognitive Functioning and Retention and Abstinence in Clients Receiving Methadone Maintenance Treatment. Acosta MC; Marsch LA; Xie H; Guarino H; Aponte-Melendez Y J Dual Diagn; 2012 Oct; 8(4):283-293. PubMed ID: 23671409 [TBL] [Abstract][Full Text] [Related]
18. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location. Kohan LR; Elmofty D; Pena I; Liao C J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425 [TBL] [Abstract][Full Text] [Related]
19. Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome. Gerra G; Borella F; Zaimovic A; Moi G; Bussandri M; Bubici C; Bertacca S Drug Alcohol Depend; 2004 Jul; 75(1):37-45. PubMed ID: 15225887 [TBL] [Abstract][Full Text] [Related]
20. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review. Frost MC; Lampert H; Tsui JI; Iles-Shih MD; Williams EC Addict Sci Clin Pract; 2021 Oct; 16(1):62. PubMed ID: 34635170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]